Atriyal fibrilasyon tanısı olan bireylerin antikoagülan tedaviye uyum ve öz-etkililik düzeylerinin belirlenmesi

Öz

Giriş ve Amaç: Atriyal fibrilasyon, toplumda sıklıkla görülen bir ritim bozukluğu türüdür ve görülme sıklığı yaşa paralel olarak artmaktadır. Atriyal fibrilasyon tanılı bireylerde inme ve arteriyel tromboemboli riski vardır. Bu araştırma atriyal fibrilasyon tanısı olan bireylerin antikoagülan tedaviye uyum ve öz-etkililik düzeylerinin belirlenmesi amacıyla tanımlayıcı tipte bir çalışma olarak gerçekleştirildi. Gereç ve Yöntem: Araştırma verileri, 01 Kasım 2022 – 28 Şubat 2023 tarihleri arasında bir üniversite hastanesinin kardiyoloji servislerinde yatan ve polikliniğe başvuran atriyal fibrilasyon tanısı olan bireylerden elde edildi. Bireylere çalışma ile ilgili bilgi verildikten sonra sözlü ve yazılı onam alındı ve yüz yüze görüşme yöntemi veriler toplandı. Araştırmada hasta bilgi formu, ilaç tedavisine bağlılık/uyum öz-etkililik ölçeği kısa formu ve ilaç uyumunu bildirim ölçeği kullanıldı. Veriler SPSS programı kullanılarak analiz edildi. Bulgular and Sonuç: Araştırmada bireylerin öz-etkililik toplam puan ortalamasının ve ilaç uyum toplam puan ortalamasının yüksek olduğu; bireylerin ilaç uyumlarının iyi düzeyde olduğu bulundu. Ek hastalığı olanların ilaç uyum toplam puanlarının, ek hastalığı olmayanların ilaç uyum toplam puanlarından yüksek olduğu saptandı. Araştırmada bireylerin ilaç tedavisine bağlılık/uyum öz-etkililik düzeyinin yüksek olmasının ilaç uyumunun artmasında etkili olduğu saptandı. Ek hastalığı olan bireylerin ilaç uyumlarının, ek hastalığı olmayanlara göre daha iyi düzeyde olduğu saptandı.

Anahtar Kelimeler

• Atrial fibrilasyon
• İlaç uyumu
• antikoagülan
• aritmi
• öz yeterlilik

Determination of anticoagulant therapy adherence and self-efficacy levels of individuals with atrial fibrillation

Öz

Introduction and Aim: Atrial fibrillation is a common type of rhythm disorder in the population, and its prevalence increases in parallel with age. Individuals with atrial fibrillation are at risk of stroke and arterial thromboembolism. This study was carried out as a descriptive study to determine the adherence and self-efficacy levels of individuals with atrial fibrillation to anticoagulant therapy. Method: The study data were obtained from individuals with a diagnosis of atrial fibrillation who were hospitalized in the cardiology services of a university hospital between November 01, 2022, and February 28, 2023. After the individuals were informed about the study, verbal and written informed consent was obtained, and data was collected by face-to-face interviews. Patient information form, medication adherence/adherence self-efficacy scale short form, and medication adherence reporting scale were used in the study. Data were analyzed using SPSS software. Results and Conclusion: In the study, it was found that the mean total score of self-efficacy and the mean total score of medication adherence were high, and the medication adherence of individuals was at a good level. It was also found that the total scores of medication adherence of those with comorbidities were higher than the total scores of those without comorbidities. The study found that higher levels of self-efficacy of adherence/compliance to medication were effective in increasing medication adherence. It was found that individuals with comorbidities had better medication adherence than those without comorbidities.

Anahtar Kelimeler

• Atrial fibrillation
• drug adherence
• anticoagulant
• arrhythmia
• self efficacy.

Kaynakça

1. Ceyhan, Y. Ş., & Ünsal, A. (2018). Comparison of the self-efficacy level of the people with different chronic diseases. E-Journal of Dokuz Eylul University Nursing Faculty, 11(4), 263–273.
2. Chen, J., Tian, Y., Yin, M., Lin, W., Tuersun, Y., Li, L., ... & He, F. (2023). Relationship between self-efficacy and adherence to self-management and medication among patients with chronic diseases in China: a multicentre cross-sectional study. Journal of psychosomatic research, 164, 111-105.
3. Demirbaş, N., & Kutlu, R. (2020). Treatment adherence and self-efficacy levels of adults using multiple drugs. Ankara Medical Journal, 20(2), 269–280.
4. Dikeç, G., & Kutlu, Y. (2015). Method for increased treatment adherence in mental disorders: Adherence therapy. Journal of Psychiatric Nursing, 6(1), 30–35.
5. Emren, S. V., Şenöz, O., Bilgin, M., Beton, O., Aslan, A., Taşkin, U., ... & Zoghi, M. (2018). Drug adherence in patients with nonvalvular atrial fibrillation taking non-vitamin K antagonist oral anticoagulants in Turkey: NOAC-TR. Clinical and Applied Thrombosis/Hemostasis, 24(3), 525-531.
6. Goli, N. M., Thompson, T., Sears, S. F., Mounsey, J. P., Chung, E., Schwartz, J., ... Gehi, A. K. (2012). Educational attainment is associated with atrial fibrillation symptom severity. Pacing and Clinical Electrophysiology, 35(9), 1090–1096.
7. Gözüm, S. (1999). Construct validation of Turkish form of the self-efficacy scale; the relationship between self-efficacy perception of cope with stress. J. Anatol. Nurs. Health. Sci., 2(1).
8. Gözüm, S., & Aksayan, S. (1999). The reliability and validity of Turkish form of the self-efficacy scale. Journal of Anatolia Nursing and Health Sciences, 2(1), 9–14.

9. Hagiwara, Y., Fujita, H., Oh, S. L., Tan, J. H., San Tan, R., Ciaccio, E. J., & Acharya, U. R. (2018). Computer-aided diagnosis of atrial fibrillation based on ECG signals: A review. Information Sciences, 467, 99–114.
10. Howren, M. B., & Gonzalez, J. S. (2016). Treatment adherence and illness self-management: introduction to the special issue. Journal of Behavioral Medicine, 39, 931-934.
11. Kansu, A. F., & Sayar, G. H. (2018). A review on the concepts of self-efficacy, meaning of life and life engagement. Academic Journal of Üsküdar University, Faculty of Communication, Etkileşim(1), 78–89.
12. Karaçağlar, E., Atar, İ., Yetiş, B., Corut, H., Ersoy, B., Yılmaz, K., ... Müderrisoğlu, H. (2012). The frequency of embolic risk factors and adequacy of anti-embolic treatment in patients with atrial fibrillation: A single tertiary center experience. The Anatolian Journal of Cardiology, 12(5), 384–390.
13. Lowres, N., Giskes, K., Hespe, C., & Freedman, B. (2019). Reducing stroke risk in atrial fibrillation: adherence to guidelines has improved, but patient persistence with anticoagulant therapy remains suboptimal. Korean Circulation Journal, 49(10), 883-907.
14. Manzoor, B. S., Lee, T. A., Sharp, L. K., Walton, S. M., Galanter, W. L., & Nutescu, E. A. (2017). Real‐world adherence and persistence with direct oral anticoagulants in adults with atrial fibrillation. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 37(10), 1221–1230.
15. Martynow, A., Lefek, K., Wierzbicka, B., Chudiak, A., Lomper, K., & Jankowska-Polańska, B. (2017). Effect of acceptance of illness on treatment adherence in atrial fibrillation patients. Journal of Education, Health and Sport, 7(5), 154-170.
16. Moudallel, S., van Laere, S., Cornu, P., Dupont, A., & Steurbaut, S. (2022). Assessment of adherence, treatment satisfaction and knowledge of direct oral anticoagulants in atrial fibrillation patients. British Journal of Clinical Pharmacology, 88(5), 2419–2429.
17. Özdemir, Ö., Akyüz, A., & Doruk, H. (2016). Compliance with drug treatment in geriatric patients with hypertension. Medical Journal of Bakırköy, 12, 195–201.
18. Özer, N. (2016). Clinical studies conducted with new oral anticoagulants in atrial fibrillation: Which oral anticoagulant can be considered for which case in light of the clinical studies? Archives of the Turkish Society of Cardiology, 44(2), 33–40.
19. Rosli, N. A., Mazapuspavina, M. Y., Ismail, Z., & Elkudssiah Ismail, N. (2022). Relationship of self-efficacy in medication understanding with quality of life among elderly with type 2 diabetes mellitus on polypharmacy in Malaysia. International Journal of Environmental Research and Public Health, 19(5), 3031.
20. Salant, P., Dillman, D. A. (1994). How to Conduct Your Own Survey, John Wiley & Sons, Inc. Newyork: 55.
21. Sarı, C., Köseoğlu, C., & Ayhan, H. (2014). Current approaches in atrial fibrillation treatment. Dicle Medical Journal, 41(3), 614–622.
22. Soyer, N. A. (2021). Rational drug use: Novel oral anticoagulants. Ege Journal of Medicine, 32–35.
23. Suzuki, T., Shiga, T., Omori, H., Tatsumi, F., Nishimura, K., & Hagiwara, N. (2017). Adherence to medication and characteristics of Japanese patients with non-valvular atrial fibrillation. Journal of Cardiology, 70(3), 238-243.
24. Şen, E. T., Berk, Ö. S., & Sindel, D. (2019). The validity and reliability study of the Turkish adaptation of medical adherence report scale. Journal of Istanbul Faculty of Medicine, 82(1), 52–61.
25. Şengül, Ş., & Uysal, H. (2019). Obstructive sleep apnea and determination of sleep quality in patients with atrial fibrillation diagnosis. Turkish Journal of Cardiovascular Nursing, 10(22), 50–58.
26. Tör, V., & Tosun, N. (2020). Investigation of medication adherence and disease-related knowledge level of hypertensive patients. Zeugma Journal of Health Researches, 2(3), 114–123.
27. Zhu, W., Ye, Z., Chen, S., Wu, D., He, J., Dong, Y., ... Liu, C. (2021). Comparative effectiveness and safety of non–vitamin K antagonist oral anticoagulants in atrial fibrillation patients. Stroke, 52(4), 1225–1233.